These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 18603138)

  • 1. The GAVI Alliance's new vaccine strategy.
    Lancet; 2008 Jul; 372(9632):2. PubMed ID: 18603138
    [No Abstract]   [Full Text] [Related]  

  • 2. Introducing new vaccines in the poorest countries: what did we learn from the GAVI experience with financial sustainability?
    Lydon P; Levine R; Makinen M; Brenzel L; Mitchell V; Milstien JB; Kamara L; Landry S
    Vaccine; 2008 Dec; 26(51):6706-16. PubMed ID: 18952134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GAVI and the Vaccine Fund--a boon for immunization in the developing world.
    Balaji KA
    Indian J Public Health; 2004; 48(2):45-8. PubMed ID: 15709583
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Making the leap into the next generation: A commentary on how Gavi, the Vaccine Alliance is supporting countries' supply chain transformations in 2016-2020.
    Brooks A; Habimana D; Huckerby G
    Vaccine; 2017 Apr; 35(17):2110-2114. PubMed ID: 28364917
    [No Abstract]   [Full Text] [Related]  

  • 5. Effect of the Global Alliance for Vaccines and Immunisation on diphtheria, tetanus, and pertussis vaccine coverage: an independent assessment.
    Lu C; Michaud CM; Gakidou E; Khan K; Murray CJ
    Lancet; 2006 Sep; 368(9541):1088-95. PubMed ID: 16997663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Financial requirements of immunisation programmes in developing countries: a 2004-2014 perspective.
    Peny JM; Gleizes O; Covilard JP
    Vaccine; 2005 Aug; 23(37):4610-8. PubMed ID: 15979769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for children in rich and poor countries.
    Shann F; Steinhoff MC
    Lancet; 1999 Sep; 354 Suppl 2():SII7-11. PubMed ID: 10507252
    [No Abstract]   [Full Text] [Related]  

  • 8. Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.
    Atherly DE; Lewis KD; Tate J; Parashar UD; Rheingans RD
    Vaccine; 2012 Apr; 30 Suppl 1():A7-14. PubMed ID: 22520139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vaccine coverage and the GAVI Alliance Immunization Services Support initiative.
    Lob-Levyt J
    Lancet; 2009 Jan; 373(9659):209. PubMed ID: 19108881
    [No Abstract]   [Full Text] [Related]  

  • 10. What We Do Not Know About the Costs of Immunization Programs in Low- and Middle-Income Countries.
    Portnoy A; Resch SC; Suharlim C; Brenzel L; Menzies NA
    Value Health; 2021 Jan; 24(1):67-69. PubMed ID: 33431155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunisation against poliomyelitis: moving forward.
    Ehrenfeld E; Glass RI; Agol VI; Chumakov K; Dowdle W; John TJ; Katz SL; Miller M; Breman JG; Modlin J; Wright P
    Lancet; 2008 Apr; 371(9621):1385-7. PubMed ID: 18424327
    [No Abstract]   [Full Text] [Related]  

  • 12. The costs of scaling up vaccination in the world's poorest countries.
    Bishai D; McQuestion M; Chaudhry R; Wigton A
    Health Aff (Millwood); 2006; 25(2):348-56. PubMed ID: 16522576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creating sustainable financing and support for immunization programs in fifteen developing countries.
    McQuestion M; Gnawali D; Kamara C; Kizza D; Mambu-Ma-Disu H; Mbwangue J; de Quadros C
    Health Aff (Millwood); 2011 Jun; 30(6):1134-40. PubMed ID: 21653967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Global health partnerships in practice: taking stock of the GAVI Alliance's new investment in health systems strengthening.
    Naimoli JF
    Int J Health Plann Manage; 2009; 24(1):3-25. PubMed ID: 19165763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects and costs of expanding the coverage of immunisation services in developing countries: a systematic literature review.
    Pegurri E; Fox-Rushby JA; Damian W
    Vaccine; 2005 Feb; 23(13):1624-35. PubMed ID: 15694515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking progress towards universal childhood immunisation and the impact of global initiatives: a systematic analysis of three-dose diphtheria, tetanus, and pertussis immunisation coverage.
    Lim SS; Stein DB; Charrow A; Murray CJ
    Lancet; 2008 Dec; 372(9655):2031-46. PubMed ID: 19070738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Financial challenges of immunization: a look at GAVI.
    Kaddar M; Lydon P; Levine R
    Bull World Health Organ; 2004 Sep; 82(9):697-702. PubMed ID: 15628208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health systems and immunization financing for human papillomavirus vaccine introduction in low-resource settings.
    Biellik R; Levin C; Mugisha E; LaMontagne DS; Bingham A; Kaipilyawar S; Gandhi S
    Vaccine; 2009 Oct; 27(44):6203-9. PubMed ID: 19698808
    [TBL] [Abstract][Full Text] [Related]  

  • 19. WHO report paints mixed picture of immunisation progress.
    Kapp C
    Lancet; 2002 Nov; 360(9346):1671. PubMed ID: 12457800
    [No Abstract]   [Full Text] [Related]  

  • 20. New vaccine adoption: qualitative study of national decision-making processes in seven low- and middle-income countries.
    Burchett HE; Mounier-Jack S; Griffiths UK; Biellik R; Ongolo-Zogo P; Chavez E; Sarma H; Uddin J; Konate M; Kitaw Y; Molla M; Wakasiaka S; Gilson L; Mills A
    Health Policy Plan; 2012 May; 27 Suppl 2():ii5-16. PubMed ID: 22513732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.